Discovery of small molecule HIV-1 integrase dimerization inhibitors.
暂无分享,去创建一个
Cristina Tintori | Silvio Massa | Zeger Debyser | Maurizio Botta | Frauke Christ | Jonas Demeulemeester | C. Tintori | M. Botta | Z. Debyser | F. Christ | J. Demeulemeester | L. Franchi | S. Massa | Luigi Franchi
[1] Thierry Langer,et al. LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters , 2005, J. Chem. Inf. Model..
[2] Robert Craigie,et al. Identification of an inhibitor-binding site to HIV-1 integrase with affinity acetylation and mass spectrometry. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[3] M. Parker,et al. Crystal structure of the HIV‐1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site , 2010, FEBS letters.
[4] M. Kvaratskhelia,et al. An Allosteric Mechanism for Inhibiting HIV-1 Integrase with a Small Molecule , 2009, Molecular Pharmacology.
[5] Z. Debyser,et al. In search of small molecules blocking interactions between HIV proteins and intracellular cofactors. , 2009, Molecular bioSystems.
[6] Z. Debyser,et al. Cellular co-factors of HIV-1 integration. , 2006, Trends in biochemical sciences.
[7] G. Schneider,et al. PocketPicker: analysis of ligand binding-sites with shape descriptors , 2007, Chemistry Central Journal.
[8] A. Voet,et al. In search of second-generation HIV integrase inhibitors: targeting integration beyond strand transfer. , 2009, Future medicinal chemistry.
[9] R. Glen,et al. Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. , 1995, Journal of molecular biology.
[10] Xiaohong Liu,et al. Dithiothreitol causes HIV-1 integrase dimer dissociation while agents interacting with the integrase dimer interface promote dimer formation. , 2011, Biochemistry.
[11] P Willett,et al. Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.
[12] Holger Gohlke,et al. The Amber biomolecular simulation programs , 2005, J. Comput. Chem..
[13] P. Kollman,et al. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.
[14] Luba Tchertanov,et al. Resistance to HIV-1 integrase inhibitors: A structural perspective. , 2010, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[15] D. Burger. Raltegravir: a review of its pharmacokinetics, pharmacology and clinical studies , 2010, Expert opinion on drug metabolism & toxicology.
[16] C. Tintori,et al. Development of an AlphaScreen-Based HIV-1 Integrase Dimerization Assay for Discovery of Novel Allosteric Inhibitors , 2012, Journal of biomolecular screening.
[17] C. Tintori,et al. Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors. , 2009, Bioorganic & medicinal chemistry letters.
[18] Martin Sippel,et al. Molecular Dynamics Simulations of the HIV-1 Integrase Dimerization Interface: Guidelines for the Design of a Novel Class of Integrase Inhibitors , 2010, J. Chem. Inf. Model..
[19] Zeger Debyser,et al. Transportin-SR2 Imports HIV into the Nucleus , 2008, Current Biology.
[20] C. Brullo,et al. Inhibition of Bcr‐Abl Phosphorylation and Induction of Apoptosis by Pyrazolo[3,4‐d]pyrimidines in Human Leukemia Cells , 2007, ChemMedChem.
[21] J. Mouscadet,et al. Peptide inhibitors of HIV-1 integrase dissociate the enzyme oligomers. , 2001, Biochemistry.
[22] M. Parker,et al. Fragment‐Based Design of Ligands Targeting a Novel Site on the Integrase Enzyme of Human Immunodeficiency Virus 1 , 2011, ChemMedChem.
[23] Laith Q Al-Mawsawi,et al. Allosteric Inhibitor Development Targeting HIV‐1 Integrase , 2011, ChemMedChem.
[24] C. Tintori,et al. A Versatile and Practical Synthesis toward the Development of Novel HIV‐1 Integrase Inhibitors , 2011, ChemMedChem.
[25] S. Ferro,et al. Inhibition of the interaction between HIV-1 integrase and its cofactor LEDGF/p75: a promising approach in anti-retroviral therapy. , 2011, Mini reviews in medicinal chemistry.
[26] Hualiang Jiang,et al. Symmetrical 1-pyrrolidineacetamide showing anti-HIV activity through a new binding site on HIV-1 integrase , 2008, Acta Pharmacologica Sinica.
[27] A. Saïb,et al. Integrase and integration: biochemical activities of HIV-1 integrase , 2008, Retrovirology.
[28] S. Boyd. Management of HIV infection in treatment-naive patients: a review of the most current recommendations. , 2011, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[29] A. Marchand,et al. Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication. , 2010, Nature chemical biology.
[30] M. Shultz,et al. Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization. , 2003, Bioorganic & medicinal chemistry letters.
[31] Richard D. Taylor,et al. Improved protein–ligand docking using GOLD , 2003, Proteins.
[32] E. Guiot,et al. Relationship between the Oligomeric Status of HIV-1 Integrase on DNA and Enzymatic Activity* , 2006, Journal of Biological Chemistry.
[33] A. Engelman,et al. Retroviral intasome assembly and inhibition of DNA strand transfer , 2010, Nature.